These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 10908014)

  • 1. Glycopeptide resistance in Staphylococcus aureus.
    Chadwick PR; Wooster SL
    J Infect; 2000 May; 40(3):211-7. PubMed ID: 10908014
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin.
    Rybak MJ; Cha R; Cheung CM; Meka VG; Kaatz GW
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):119-25. PubMed ID: 15698717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D; Toshkova K; Gavrilova V
    Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of spontaneous resistance to glycopeptide antibiotics in staphylococcal populations.
    Biavasco F; Montanari MP; Facinelli B; Varaldo PE
    J Chemother; 1989 Jul; 1(4 Suppl):389-90. PubMed ID: 16312453
    [No Abstract]   [Full Text] [Related]  

  • 6. Staph with lower vancomycin resistance in US.
    OR Manager; 1997 Oct; 13(10):7. PubMed ID: 10174189
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
    Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
    Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
    Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
    Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
    [No Abstract]   [Full Text] [Related]  

  • 9. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
    Goldstein FW; Atoui R; Ben Ali A; Nguyen JC; Ly A; Kitzis MD
    Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals.
    Borg MA; Zerafa R; Morrison D; Cuschieri P
    Clin Microbiol Infect; 2005 May; 11(5):405-7. PubMed ID: 15819869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting vancomycin intermediate Staphylococcus aureus.
    Commun Dis Rep CDR Wkly; 1997 Nov; 7(47):417, 20. PubMed ID: 9401190
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].
    Manfredi R; Nanetti A; Morelli S; Valentini R; Ferri M; Calza L; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):344. PubMed ID: 12868245
    [No Abstract]   [Full Text] [Related]  

  • 13. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
    Aepfelbacher M
    MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
    Mallaval FO; Carricajo A; Delavenna F; Recule C; Fonsale N; Manquat G; Raffenot D; Rogeaux O; Aubert G; Tous J
    Clin Microbiol Infect; 2004 May; 10(5):459-61. PubMed ID: 15113326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
    Pina P; Marliere C; Vandenesch F; Bedos JP; Etienne J; Allouch PY
    Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
    Mariani PG; Sader HS; Jones RN
    J Antimicrob Chemother; 2006 Aug; 58(2):481-3. PubMed ID: 16847029
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in: a Belgian hospital].
    Piérard D; Vandenbussche H; Verschraegen I; Lauwers S
    Pathol Biol (Paris); 2004 Oct; 52(8):486-8. PubMed ID: 15465269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of vancomycin-intermediate Staphylococcus aureus and S. sciuri, Greece.
    Tsakris A; Papadimitriou E; Douboyas J; Stylianopoulou F; Manolis E
    Emerg Infect Dis; 2002 May; 8(5):536-7. PubMed ID: 11996696
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
    Bernard L; Vaudaux P; Rohner P; Huggler E; Armanet M; Pittet D; Lew DP; Schrenzel J
    J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.